4.7 Review

Glucocorticoid Receptor Signaling in Diabetes

Journal

Publisher

MDPI
DOI: 10.3390/ijms222011173

Keywords

glucocorticoids; glucocorticoid receptor; GR; diabetes mellitus; stress

Funding

  1. European Regional Development Fund of the European Union
  2. Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation [T1EDK-00235]

Ask authors/readers for more resources

Research shows that stress and depression increase the risk of Type 2 Diabetes by impairing the negative feedback of Glucocorticoid in patients, leading to HPA axis hyperactivity and hypercortisolism. Glucocorticoid Receptor has a key role in regulating glucose homeostasis in peripheral tissues, while impaired signaling in Peripheral Blood Mononuclear Cells of T2D patients is linked to metabolic disturbances. Further investigation into selective modulation of GR signaling in T2D therapy is warranted.
Stress and depression increase the risk of Type 2 Diabetes (T2D) development. Evidence demonstrates that the Glucocorticoid (GC) negative feedback is impaired (GC resistance) in T2D patients resulting in Hypothalamic-Pituitary-Adrenal (HPA) axis hyperactivity and hypercortisolism. High GCs, in turn, activate multiple aspects of glucose homeostasis in peripheral tissues leading to hyperglycemia. Elucidation of the underlying molecular mechanisms revealed that Glucocorticoid Receptor (GR) mediates the GC-induced dysregulation of glucose production, uptake and insulin signaling in GC-sensitive peripheral tissues, such as liver, skeletal muscle, adipose tissue, and pancreas. In contrast to increased GR peripheral sensitivity, an impaired GR signaling in Peripheral Blood Mononuclear Cells (PBMCs) of T2D patients, associated with hyperglycemia, hyperlipidemia, and increased inflammation, has been shown. Given that GR changes in immune cells parallel those in brain, the above data implicate that a reduced brain GR function may be the biological link among stress, HPA hyperactivity, hypercortisolism and hyperglycemia. GR polymorphisms have also been associated with metabolic disturbances in T2D while dysregulation of micro-RNAs-known to target GR mRNA-has been described. Collectively, GR has a crucial role in T2D, acting in a cell-type and context-specific manner, leading to either GC sensitivity or GC resistance. Selective modulation of GR signaling in T2D therapy warrants further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available